2021
DOI: 10.3390/biomedicines9050470
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological and Therapeutic Approaches in the Treatment of Epilepsy

Abstract: Epilepsy affects around 50 million people across the globe and is the third most common chronic brain disorder. It is a non-communicable disease of the brain that affects people of all ages. It is accompanied by depression, anxiety, and substantially increased morbidity and mortality. A large number of third-generation anti-epileptic drugs are available, but they have multiple side-effects causing a decline in the quality of life. The inheritance and etiology of epilepsy are complex with multiple underlying ge… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(18 citation statements)
references
References 82 publications
(108 reference statements)
0
18
0
Order By: Relevance
“…However, each model has its own advantages and disadvantages compared with other models, and the appropriate model needs to be selected according to the experimental requirements. [36][37][38][39][40] All existing animal models have limitations, and they cannot fully simulate the characteristics of human TLE.…”
Section: Discussionmentioning
confidence: 99%
“…However, each model has its own advantages and disadvantages compared with other models, and the appropriate model needs to be selected according to the experimental requirements. [36][37][38][39][40] All existing animal models have limitations, and they cannot fully simulate the characteristics of human TLE.…”
Section: Discussionmentioning
confidence: 99%
“…Current anti-epileptic drugs primarily target glutamate receptors or GABA receptors, thereby inhibiting seizures. However, long-term drug therapy may produce severe side effects, and some patients still develop drug resistance ( Ghosh et al, 2021 ). Approximately 30–40% of people with epilepsy are resistant to traditional anti-epileptic drugs ( Li et al, 2022 ).…”
Section: Potential Of Medial Ganglionic Eminence Cell Transplantation...mentioning
confidence: 99%
“…Some underlying genetic factors, brain injuries, tumours, or dysregulated microRNAs have been identified to be the cause of epilepsy, but in 60% of the cases, the source is unknown [ 58 ]. Substantial progress has been made in terms of treatment, comprising anti-convulsants [ 59 ], neuromodulation [ 60 ], and dietary regulations, such as ketogenic diet [ 61 ]. Nonetheless, about a third of patients continue to experience seizures [ 61 ], leaving surgery as the sole remaining option.…”
Section: Also In This Issuementioning
confidence: 99%